Key statistics
On Thursday, Tandem Diabetes Care Inc (T2ND34:SAO) closed at 16.00, -15.34% below its 52-week high of 18.90, set on May 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.85 |
---|---|
High | 16.00 |
Low | 15.85 |
Bid | 15.86 |
Offer | 16.55 |
Previous close | 15.70 |
Average volume | 1.12k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 19 2024 20:54 BST.
More ▼
Press releases
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
- Tandem Diabetes Care Announces Upcoming Conference Participation
- Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
- Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
- Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
- Tandem Diabetes Care Announces Upcoming Conference Presentation
- Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
More ▼